Fundings help start-ups to expand their research and development capabilities, as well as to create new technology.

Preventive or analytic systems are part of health technology. For example, fitness monitors and diet plans. And on the other hand, Medtech is a term used for hospital and medical facility cure systems. The health-tech business is expanding, but it is taking longer than expected since all of the data regulations and procedures were once kept on paper. As a result, converting them to digital formats takes a long time. The health-tech market is divided into six categories. Ehealth, e-pharmacy, medical IT, analytics, home care, individual health monitoring, fitness, and wellness are among the several verticals.

On Thursday, Traya, a health care startup, announced that it has secured US$2.2 million in a fundraising round headed by Fireside Ventures. The round included institutional shareholders Kae Capital and Whiteboard Capital. “Of more than 1,00,000 patients Traya treated last year, 76 percent had digestive difficulties, 78 percent had dandruff issues, 52 percent had anemia, 36 percent had IBS, 22 percent had thyroid, and 16 percent had PCOS,” said AltafSaiyed, cofounder of Traya. Traya assists individuals in determining the kind, stage, and fundamental cause of their illness and then creates a treatment plan based on that information. An ayurvedic doctor and a dermatologist monitor, alter and recommend the best treatment plan to various patients. Their diet aids in the management of these fundamental reasons, as well as hair growth, for long-term outcomes.

Innovaccer, a health tech start-up, has secured US$150 million in a Series E fundraising round headed by Mubadala Capital, valuing the company at US$3.2 billion.

In addition to B Capital Group, Microsoft’s M12 fund, OMERS Growth Equity, Dragoneer, Steadview Capital, Tiger Global Management, Whale Rock Capital Management, Avidity Partners, and Schonfeld Strategic Advisors, other investors in this round included B Capital Group, Microsoft’s M12 fund, OMERS Growth Equity, Dragoneer, Steadview Capital, Tiger Global Management, Whale Rock Capital Management, Avidity Partners, and Schonfeld Strategic Advisors. Innovacer has already received approximately US$375 million in the capital.

Heaps Health, a Mumbai-based AI-driven healthcare firm, has secured US$7.45 million in a Series A round of investment. NVS Wealth Managers and Rajiv Dadlani Group spearheaded the new capital injection. The business plans to use the additional funds to expand its workforce and speed up product development. Heaps Health is planning to consolidate its position in existing markets and expand into new territory. Heaps, a network-as-a-service provider that provides insurers, hospitals, and companies with AI-based patient engagement platforms, said it expects to use the additional funds to grow its staff, expedite product development and optimization, and expand into new areas.

According to a Dec. 20 article by EU startups, German health technology firm Formel Skin has raised 30 million euros (US$33.8 million) in a Series A fundraising round for its dermatological platform. The round, led by Singular, a Paris-based VC firm, and Heal Capital, a German HealthTech investor, increases the company’s total investment to 36 million euros (US$40.6 million), making it one of Europe’s fastest-growing health technology businesses.

According to market research, the size of the market and revenue of Digital Health will grow from US$84.08 billion in 2019 to US$220.94 billion in 2026. Between 2021-2026, this increment will grow at a CAGR of 14.8% each year. CISCO Systems, Vodafone Group, Allscripts, Cerner Corporation, Google Inc, AT&T, and many more are crucial stakeholders in the global health tech business.

Now that investors are aware of health tech businesses, they are pouring money into them. The following are some of the prior health tech start-up fundings:

• Innovaccer was awarded a US$225 million grant
• Pharmeasy, which obtained US$651.5 million in investment, and 1mg, which received US$191.3 million in finance
• Curefit was awarded US$404.6 million in financing
• Practo, which garnered US$232 million in investment

Indian health tech businesses aren’t only treating fevers and skin rashes anymore; they’re also treating deadly conditions like cancer. In 2021, dubbed “businesses year,” four healthcare startups rose to become unicorns. It all started in Delhi when Innovaccer, a California-based business that competes with Heaps Health, entered the fray with a $115 million investment. Curefit, PharmEasy, and Pristyn Care are three more healthcare firms that have reached a billion-dollar value this year.